Visiox Pharmaceuticals Merges With Ocuvex Therapeutics
19 Aug 2024 //
PR NEWSWIRE
Visiox and Ocuvex Merge to Form Ophthalmic Powerhouse
19 Aug 2024 //
CONTRACT PHARMA
Visiox Pharma Appoints Richard J. Rubino to Board of Directors
17 Aug 2023 //
PR NEWSWIRE
Visiox Pharma Licenses OMLONTI®
19 Jul 2023 //
PR NEWSWIRE
Santen Agrees to Licensing Agreements for its Pharmaceutical Products
18 Jul 2023 //
BUSINESSWIRE
Visiox Pharma Appoints Sanjay Malieckal as Vice President
05 Jul 2023 //
PR NEWSWIRE
Visiox Pharma Announces FDA Acceptance of New Drug Application for Glaucoma
08 Dec 2022 //
PRNEWSWIRE
Visiox Appoints Industry Veteran Cynthia Matossian, as Chief Medical Officer
13 Oct 2022 //
PRNEWSWIRE